Vogenx, Inc.

VOGX chart

Vogenx, Inc. news

• Weekly Recap: Q3 net loss of $4.9 million and EMERGE Phase 2b launch

  TradingView · Nov 9, 6:00 AM EST

• Vogenx Posts $0.47 Q3 GAAP Loss Per Share, Missing Estimate by $0.40

  TOKENPOST · Nov 8, 6:49 AM EST

• Vogenx (Nasdaq:VOGX) - Stock Analysis

  Simply Wall St · Nov 8, 4:24 AM EST

• Vogenx, Inc. (1Q8.F) latest stock news and headlines

  Yahoo Finance UK · Nov 7, 2:52 PM EST

• Vogenx 3Q 2026: EPS ($0.47) — 10-Q Summary

  TradingView · Nov 6, 5:31 PM EST

• A $3.4M non-cash warrant loss adds to the quarterly red ink at Vogenx (VOGX).

  Stock Titan · Nov 6, 5:24 PM EST

• Vogenx Posts $4.9M Quarterly Net Loss, $82.1M Cash After August IPO, Launches Phase 2b PBH Study

  Minichart · Nov 6, 11:35 AM EST

• Vogenx Q3 2026 Earnings Results and Report

  MarketBeat · Nov 6, 8:44 AM EST

• Vogenx Q3FY26 Results: EPS misses estimate, net loss widens to $4.9 million

  scanx.trade · Nov 6, 7:38 AM EST

• Form 8K VOGENX For: 6 November By Investing.com

  Investing.com UK · Nov 6, 6:52 AM EST

• Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights

  Yahoo Finance · Nov 6, 6:30 AM EST

• Vogenx (VOGX) Q3 Net Loss Widens to $4.9M

  TradingView · Nov 6, 6:30 AM EST

Vogenx, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-QFORM 10-Q2026-11-06
• 8-KFORM 8-K2026-11-06
• 8-KFORM 8-K2026-10-09
• 8-KFORM 8-K2026-09-22
• 10-QFORM 10-Q2026-09-17
• 8-KFORM 8-K2026-08-19
• 8-KFORM 8-K2026-08-13
• S-1FORM S-12026-07-15

About Vogenx, Inc.

Ticker

VOGX (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Raleigh, NC

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1903784

Frequently asked questions